Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 145-156 of 1610 results.
"Midline catheters demonstrated no significant differences in the thrombotic profile compared to PICCs. Therefore, VTE risk alone should not determine catheter choice. Future prospective studies with standardized definitions and improved reporting are essential to guide optimal vascular access choice" Santagata et al (2026).
"Intravenous fluids and vasoactive medications represent the foundation of hemodynamic resuscitation for septic shock. Based on current evidence, initial fluid resuscitation of roughly 30 mL/kg with balanced crystalloids is reasonable for most patients" Graham et al (2026).
"This is the first report of the use of SASS in HD t-CVC. In our experience, SecurAcath® was safe and effective for stabilization of Tesio t-CVC" Guzzi et al (2026).
"This prospective, single-arm, first-in-human study evaluated the feasibility and safety of the fully subcutaneous IO device over a 7-day implant with daily infusions in patients with challenging venous access or CKD" Ulloa et al (2026).
"Nurses who had received prior training in dialysis vascular access management demonstrated better knowledge" Zhao et al (2026).
"In this report, low-volume centrifugal PLEX to treat liver disease was performed via peripheral venous access in 18% of patients. P-PLEX was done in the ward, with similar efficiency and better line-related safety; however, the PLEX duration was prolonged by 30 min" Janeela et al (2026).
"This study aims to determine the impact and potential relationship between maturation rates of upper limb arteriovenous fistulas and a previous history of central venous catheter placement for hemodialysis" Ruben-Castillo et al (2026).
"The prevalence of drugs with a high risk of phlebitis in intensive care units is elevated. Drug physicochemical properties significantly influence the risk of phlebitis and should be incorporated into bedside vascular-access selection" Gallardo et al (2026).
"his systematic review and Bayesian network meta-analysis synthesized available evidence by comparing different CLs directly and indirectly to prevent CLABSI and rank their effectiveness" Liu et al (2026).
"A surveillance program is recommended to monitor outcomes and compliance with bundles. Ongoing review of the performance data with appropriate interventions made should facilitate efforts towards zero CLABSI rate" Ling et al (2026).
"OPAT proved to be an effective and safe strategy for managing Gram-negative infections in immunocompromised patients. Close clinical and laboratory monitoring contributed to favorable outcomes. Further studies are needed to optimize OPAT protocols in this population" Passerotto et al (2026).
"A large healthcare system launched a quality improvement initiative to reduce pump alarms and minimize residual volume by implementing customized tubing solutions" Pouliot et al (2026).
